{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:32:40Z","timestamp":1793831560095,"version":"4.6.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"DOI":"10.1007\/s10103-025-04293-2","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T18:54:56Z","timestamp":1736880896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trial"],"prefix":"10.1007","volume":"40","author":[{"given":"Ghasem Rahmatpour","family":"Rokni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Malekan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepide","family":"Azade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Mohammad","family":"Beyzaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armaghan","family":"Kazeminejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Zaresharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-270X","authenticated-orcid":false,"given":"Nasim","family":"Gholizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"6","key":"4293_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Ezzedine K, Vitiligo (2020) A review. Dermatology 236(6):571\u2013592. https:\/\/doi.org\/10.1159\/000506103","journal-title":"Dermatology"},{"issue":"1","key":"4293_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jamadermatol.2021.4724","volume":"158","author":"K Gandhi","year":"2022","unstructured":"Gandhi K, Ezzedine K, Anastassopoulos KP, Patel R, Sikirica V, Daniel SR, Napatalung L, Yamaguchi Y, Baik R, Pandya AG (2022) Prevalence of Vitiligo among adults in the United States. JAMA Dermatology 158(1):43\u201350. https:\/\/doi.org\/10.1001\/jamadermatol.2021.4724","journal-title":"JAMA Dermatology"},{"key":"4293_CR3","doi-asserted-by":"publisher","unstructured":"Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, Gonz\u00e1lez U, Jiyad Z, Eleftheriadou V, Ezzedine K (2015) Interventions for vitiligo. Cochrane Database Syst Rev 2Cd003263. https:\/\/doi.org\/10.1002\/14651858.CD003263.pub5","DOI":"10.1002\/14651858.CD003263.pub5"},{"issue":"2","key":"4293_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40257-022-00752-6","volume":"24","author":"KN Cunningham","year":"2023","unstructured":"Cunningham KN, Rosmarin D (2023) Vitiligo treatments: review of current therapeutic modalities and JAK inhibitors. Am J Clin Dermatol 24(2):165\u2013186. https:\/\/doi.org\/10.1007\/s40257-022-00752-6","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"4293_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaad.2016.11.010","volume":"77","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE (2017) Current and emerging treatments for vitiligo. J Am Acad Dermatol 77(1):17\u201329. https:\/\/doi.org\/10.1016\/j.jaad.2016.11.010","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"4293_CR6","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/jocd.15594","volume":"22","author":"SE El-Mongy","year":"2023","unstructured":"El-Mongy SE, Ghanem BM, El-Shrbeny Y (2023) Platelet-rich plasma injection versus combined fractional carbon dioxide laser with platelet-rich plasma in treatment of vitiligo: a comparative study. J Cosmet Dermatol 22(5):1699\u20131701. https:\/\/doi.org\/10.1111\/jocd.15594","journal-title":"J Cosmet Dermatol"},{"key":"4293_CR7","doi-asserted-by":"publisher","first-page":"750342","DOI":"10.1155\/2011\/750342","volume":"2011","author":"T Kawakami","year":"2011","unstructured":"Kawakami T, Hashimoto T (2011) Disease severity indexes and treatment evaluation criteria in vitiligo. Dermatology Res Pract 2011:750342. https:\/\/doi.org\/10.1155\/2011\/750342","journal-title":"Dermatology Res Pract"},{"issue":"4","key":"4293_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5826\/dpc.0404a18","volume":"4","author":"A Feily","year":"2014","unstructured":"Feily A (2014) Vitiligo Extent Tensity Index (VETI) score: a new definition, assessment and treatment evaluation criteria in vitiligo. Dermatology Practical Concept 4(4):81\u201384. https:\/\/doi.org\/10.5826\/dpc.0404a18","journal-title":"Dermatology Practical Concept"},{"issue":"Suppl 1","key":"4293_CR9","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1111\/j.1524-4733.2005.00066.x","volume":"8","author":"MJ Atkinson","year":"2005","unstructured":"Atkinson MJ, Kumar R, Cappelleri JC, Hass SL (2005) Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health: J Int Soc Pharmacoeconomics Outcomes Res 8(Suppl 1):S9\u2013s24. https:\/\/doi.org\/10.1111\/j.1524-4733.2005.00066.x","journal-title":"Value Health: J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"4293_CR10","doi-asserted-by":"publisher","unstructured":"Domaszewska-Szostek A, Polak A, S\u0142upecka-Ziemilska M, Krzy\u017canowska M, Puzianowska-Ku\u017anicka M (2023) Current status of cell-based therapies for Vitiligo. Int J Mol Sci 24(4). https:\/\/doi.org\/10.3390\/ijms24043357","DOI":"10.3390\/ijms24043357"},{"issue":"2","key":"4293_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pcmr.12949","volume":"34","author":"J Seneschal","year":"2021","unstructured":"Seneschal J, Boniface K, D\u2019Arino A, Picardo M (2021) An update on Vitiligo pathogenesis. Pigment cell Melanoma Res 34(2):236\u2013243. https:\/\/doi.org\/10.1111\/pcmr.12949","journal-title":"Pigment cell Melanoma Res"},{"issue":"3","key":"4293_CR12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12016-021-08868-z","volume":"61","author":"Y Wang","year":"2021","unstructured":"Wang Y, Li S, Li C (2021) Clinical features, immunopathogenesis, and therapeutic strategies in Vitiligo. Clin Rev Allergy Immunol 61(3):299\u2013323. https:\/\/doi.org\/10.1007\/s12016-021-08868-z","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"4293_CR13","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1468-3083.2006.02132.x","volume":"21","author":"MA Middelkamp-Hup","year":"2007","unstructured":"Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W (2007) Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study. J Eur Acad Dermatology Venereology: JEADV 21(7):942\u2013950. https:\/\/doi.org\/10.1111\/j.1468-3083.2006.02132.x","journal-title":"J Eur Acad Dermatology Venereology: JEADV"},{"issue":"8","key":"4293_CR14","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1111\/jdv.14882","volume":"32","author":"S Sharma","year":"2018","unstructured":"Sharma S, Parsad D, Bhattacharjee R, Muthu SK (2018) A prospective right-left comparative study to evaluate the efficacy and tolerability of combination of NB-UVB and topical bimatoprost 0.03% eye drops versus NB-UVB given alone in patients of vitiligo vulgaris. J Eur Acad Dermatology Venereology: JEADV 32(8):e330\u2013e1. https:\/\/doi.org\/10.1111\/jdv.14882","journal-title":"J Eur Acad Dermatology Venereology: JEADV"},{"issue":"9","key":"4293_CR15","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s10103-017-2290-y","volume":"32","author":"MB El-Zawahry","year":"2017","unstructured":"El-Zawahry MB, Zaki NS, Wissa MY, Saleh MA (2017) Effect of combination of fractional CO(2) laser and narrow-band ultraviolet B versus narrow-band ultraviolet B in the treatment of non-segmental vitiligo. Lasers Med Sci 32(9):1953\u20131958. https:\/\/doi.org\/10.1007\/s10103-017-2290-y","journal-title":"Lasers Med Sci"},{"issue":"12","key":"4293_CR16","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.1111\/jocd.15396","volume":"21","author":"J Helou","year":"2022","unstructured":"Helou J, Soutou B, Maatouk I, Merhy R, Assaf J, Sarkis AS, Jabbour R, Kaikati J, Tomb R (2022) Beneficial UVB phototherapy preceding a fractional CO(2) laser-UVB protocol in refractory non-segmental vitiligo. J Cosmet Dermatol 21(12):6783\u20136787. https:\/\/doi.org\/10.1111\/jocd.15396","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"4293_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2133.2011.10324.x","volume":"165","author":"R Kumar","year":"2011","unstructured":"Kumar R, Parsad D, Kanwar AJ, Kaul D (2011) Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo. Br J Dermatol 165(2):285\u2013291. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10324.x","journal-title":"Br J Dermatol"},{"issue":"11","key":"4293_CR18","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1046\/j.1524-4725.1999.99091.x","volume":"25","author":"EV Ross","year":"1999","unstructured":"Ross EV, Yashar SS, Naseef GS, Barnette DJ, Skrobal M, Grevelink J, Anderson RR (1999) A pilot study of in vivo immediate tissue contraction with CO2 skin laser resurfacing in a live farm pig. Dermatol Surgery: Official Publication Am Soc Dermatol Surg [et al] 25(11):851\u2013856. https:\/\/doi.org\/10.1046\/j.1524-4725.1999.99091.x","journal-title":"Dermatol Surgery: Official Publication Am Soc Dermatol Surg [et al]"},{"issue":"1","key":"4293_CR19","doi-asserted-by":"publisher","first-page":"e14604","DOI":"10.1111\/dth.14604","volume":"34","author":"RM Bakr","year":"2021","unstructured":"Bakr RM, Abdel-Gaber RM, Tawfik YM (2021) A comparative study on the use of fractional CO(2) laser with tacrolimus or calcipotriol or narrow band ultraviolet-B in treatment of stable nonsegmental vitiligo. Dermatol Ther 34(1):e14604. https:\/\/doi.org\/10.1111\/dth.14604","journal-title":"Dermatol Ther"},{"issue":"7","key":"4293_CR20","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s10103-020-03195-9","volume":"36","author":"AA Afify","year":"2021","unstructured":"Afify AA, Zuelfakkar NM, Eshafi MA (2021) Fractional CO2 laser, platelet rich plasma and narrow band ultraviolet B in the treatment of Vitiligo (a randomized clinical trial). Lasers Med Sci 36(7):1479\u20131486. https:\/\/doi.org\/10.1007\/s10103-020-03195-9","journal-title":"Lasers Med Sci"},{"issue":"3","key":"4293_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/jocd.12397","volume":"17","author":"R Abdelghani","year":"2018","unstructured":"Abdelghani R, Ahmed NA, Darwish HM (2018) Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: a prospective, randomized comparative trial. J Cosmet Dermatol 17(3):365\u2013372. https:\/\/doi.org\/10.1111\/jocd.12397","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"4293_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/lsm.22389","volume":"48","author":"V Vachiramon","year":"2016","unstructured":"Vachiramon V, Chaiyabutr C, Rattanaumpawan P, Kanokrungsee S (2016) Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas. Lasers Surg Med 48(2):197\u2013202. https:\/\/doi.org\/10.1002\/lsm.22389","journal-title":"Lasers Surg Med"},{"issue":"7","key":"4293_CR23","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s10103-016-1982-z","volume":"31","author":"S Kanokrungsee","year":"2016","unstructured":"Kanokrungsee S, Chanprapaph K, Chaiyabutr C, Vachiramon V (2016) A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo. Lasers Med Sci 31(7):1343\u20131349. https:\/\/doi.org\/10.1007\/s10103-016-1982-z","journal-title":"Lasers Med Sci"},{"issue":"3","key":"4293_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/dth.12202","volume":"28","author":"L Li","year":"2015","unstructured":"Li L, Wu Y, Li L, Sun Y, Qiu L, Gao XH, Chen HD (2015) Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study. Dermatol Ther 28(3):131\u2013134. https:\/\/doi.org\/10.1111\/dth.12202","journal-title":"Dermatol Ther"},{"issue":"3","key":"4293_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1365-2133.2011.10723.x","volume":"166","author":"J Shin","year":"2012","unstructured":"Shin J, Lee JS, Hann SK, Oh SH (2012) Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study. Br J Dermatol 166(3):658\u2013661. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10723.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"4293_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/jocd.12553","volume":"18","author":"NN Doghaim","year":"2019","unstructured":"Doghaim NN, Gheida SF, El-Tatawy RA, Mohammed Ali DA (2019) Combination of fractional carbon dioxide laser with narrow band ultraviolet B to induce repigmentation in stable vitiligo: a comparative study. J Cosmet Dermatol 18(1):142\u2013149. https:\/\/doi.org\/10.1111\/jocd.12553","journal-title":"J Cosmet Dermatol"},{"issue":"7","key":"4293_CR27","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/09546634.2018.1564232","volume":"30","author":"S Ghasemloo","year":"2019","unstructured":"Ghasemloo S, Gauthier Y, Ghalamkarpour F (2019) Evaluation of using fractional CO(2) laser plus NB-UVB versus NB-UVB alone in inducing marginal repigmentation of vitiligo lesions. J Dermatolog Treat 30(7):697\u2013700. https:\/\/doi.org\/10.1080\/09546634.2018.1564232","journal-title":"J Dermatolog Treat"},{"issue":"12","key":"4293_CR28","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1097\/dss.0000000000001890","volume":"45","author":"P E\u015fme","year":"2019","unstructured":"E\u015fme P, G\u00fcr Aksoy G, El\u00e7in G (2019) No additional benefit of combining Fractional Carbon Dioxide Laser with narrow-Band Ultraviolet B Phototherapy for Vitiligo: a randomized prospective study with half-body side comparison. Dermatol Surgery: Official Publication Am Soc Dermatol Surg [et al] 45(12):1627\u20131634. https:\/\/doi.org\/10.1097\/dss.0000000000001890","journal-title":"Dermatol Surgery: Official Publication Am Soc Dermatol Surg [et al]"},{"issue":"2","key":"4293_CR29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2340\/00015555-2836","volume":"98","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Hong ES, Cho SH, Lee JD, Kim HS (2018) Fractional Carbon Dioxide Laser as an add-on treatment for Vitiligo: a Meta-analysis with systematic review. Acta dermato-venereologica 98(2):180\u2013184. https:\/\/doi.org\/10.2340\/00015555-2836","journal-title":"Acta dermato-venereologica"},{"issue":"7","key":"4293_CR30","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s10103-018-2516-7","volume":"33","author":"YJ Chiu","year":"2018","unstructured":"Chiu YJ, Perng CK, Ma H, Fractional (2018) CO(2) laser contributes to the treatment of non-segmental vitiligo as an adjunct therapy: a systemic review and meta-analysis. Lasers Med Sci 33(7):1549\u20131556. https:\/\/doi.org\/10.1007\/s10103-018-2516-7","journal-title":"Lasers Med Sci"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04293-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-025-04293-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-025-04293-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:23:58Z","timestamp":1771399438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-025-04293-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4293"],"URL":"https:\/\/doi.org\/10.1007\/s10103-025-04293-2","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"14 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"19"}}